GlassScriptPhysician profile
Andrew Peter Dold
NPI 1932576980
$107,000.87
in general payments reported to CMS, 2019-2025
38 companies · $4,357 in 2025
The $4,357 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $5,862 · 2021: $26K · 2022: $1,695 · 2023: $22K · 2024: $21K · 2025: $4,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $9,378 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,188 · Food and Beverage: $7,038 · Education: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,687.50 |
| Travel and Lodging | $9,377.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,187.50 |
| Food and Beverage | $7,037.83 |
| Education | $750.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $41,424.46 | 2019-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Novostitch |
| Terumo Bct, INC. | $13,286.18 | 2019-2021 | |
| Medical Device Business Services, INC. | $12,496.38 | 2019-2025 | |
| Horizon Therapeutics Plc | $8,180.43 | 2020-2022 | |
| Depuy Synthes Products, INC. | $7,369.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $6,261.20 | 2019-2024 | Exparel, Iovera, Zilretta |
| Stryker Corporation | $4,463.50 | 2019-2025 | Iconix, Pangea, Cinchlock |
| Zimmer Biomet Holdings, INC. | $4,160.35 | 2019-2025 | Persona, Avenir, Oxford |
| Linvatec Corporation | $2,451.34 | 2024 | Biobrace 23mm |
| Pylant Medical | $2,438.83 | 2019-2024 | |
| Depuy Synthes Sales INC. | $1,407.79 | 2019-2025 | Lcp, Actis, Va-Lcp |
| Vericel Corporation | $1,072.86 | 2020-2025 | Maci |
| Microport Orthopedics INC | $747.05 | 2019 | |
| Ferring Pharmaceuticals INC. | $139.24 | 2020-2025 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $126.70 | 2022-2023 | Seglentis |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthalign INC | $109.79 | 2019 | |
| Rti Surgical, INC | $96.14 | 2025 | |
| Orthofix Medical, INC. | $90.53 | 2019-2023 | Physio-Stim |
| Bioventus LLC | $64.92 | 2025 | Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $52.44 | 2023-2025 | Irrisept |
| Highridge Medical LLC | $51.87 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Cumberland Pharmaceuticals, INC. | $51.61 | 2022-2023 | Caldolor |
| Ethicon US, LLC | $47.16 | 2022-2025 | Vistaseal, Dermabond Prineo |
| Globus Medical, INC. | $43.11 | 2023 | Troch Nail |
| Boston Scientific Corporation | $40.63 | 2022 | |
| Moximed, INC | $32.34 | 2025 | Misha Knee System, Small, Left |
| Ebi, LLC | $32.33 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Henry Schein, INC. | $32.24 | 2024 | |
| Flower Orthopedics Coporation | $30.86 | 2022 | |
| Precision Medical Products, INC. | $29.74 | 2020 | |
| Solventum Corporation | $25.78 | 2024 | Prevena |
| Ermi LLC | $25.06 | 2019 | |
| Medtronic, INC. | $24.89 | 2022 | |
| Lazurite INC. | $21.65 | 2024 | |
| Mimedx Group, INC. | $20.70 | 2025 | |
| Integra Lifesciences Corporation | $19.49 | 2022 | |
| Baxter Healthcare | $16.73 | 2022 | |
| Avanos Medical | $15.27 | 2024 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.